Latest News about NRXP
Recent news which mentions NRXP
20 Stocks Moving in Thursday's Pre-Market Session
May 26, 2022
From Benzinga
From Benzinga
Earnings Scheduled For May 16, 2022
May 16, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
April 21, 2022
From Benzinga
NRx Pharmaceuticals Again Requests For FDA Breakthrough Therapy Status For COVID-19 Therapy
April 21, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Friday
April 08, 2022
From Benzinga
53 Biggest Movers From Yesterday
April 01, 2022
From Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
March 31, 2022
From Benzinga
36 Stocks Moving In Thursday's Mid-Day Session
March 31, 2022
From Benzinga
Earnings Scheduled For March 31, 2022
March 31, 2022
From Benzinga
NRX Pharmaceuticals Q4 2021 Earnings Conference Call On March 31, 2022 At 08:30 AM ET
March 29, 2022
Tickers
NRXP
From Benzinga
87 Biggest Movers From Yesterday
March 10, 2022
From Benzinga
From Benzinga
26 Stocks Moving in Friday's Pre-Market Session
February 18, 2022
From Benzinga
52 Biggest Movers From Yesterday
February 15, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
February 08, 2022
From Benzinga
The Daily Biotech Pulse: Big Pharma Earnings Prove Lackluster, Mersana Inks $1B ADC R&D Deal, Syros Gets Orphan Drug Designation
February 03, 2022
From Benzinga
Mid-Afternoon Market Update: Nasdaq Jumps 375 Points; Imperial Petroleum Shares Drop
January 31, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Monday
January 31, 2022
From Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
January 31, 2022
From Benzinga
32 Stocks Moving In Monday's Mid-Day Session
January 31, 2022
From Benzinga
The Daily Biotech Pulse: Gilead's Blood Cancer Studies Placed On Partial Clinical Hold, Immunocore Gets FDA Nod, NRx Touts Positive COVID-19 Data
January 26, 2022
From Benzinga
NRx Receives Initial Report of Patient Safety From 'Right To Try' Use Of Zyesami For COVID-19
January 26, 2022
Tickers
NRXP
From Benzinga
3 Under-the-Radar COVID Stocks
January 19, 2022
From Motley Fool
NRx Pharma's Zyesami Access Expanded To COVID-19 Patients Who Exhausted All Approved Treatments
January 18, 2022
Tickers
NRXP
From Benzinga
The Daily Biotech Pulse: Adagio's Antibody Effective Against Omicron, Sarepta Terminates Gene Therapy Deal, AstraZeneca Inks Oncology Pact
January 13, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.